Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

What is the Mechanism for Blood Clotting in COVID-19?

THROMBOSIS is a significant contributor to morbidity and mortality in coronavirus disease-2019 (COVID-19), and researchers may have identified the…

hematology 8.1 featured image

Review of the European Hematology Association (EHA) Virtual Congress 2020

Twenty-five years of the EHA annual congress have meant 25 years of inspiring innovations and scientific results contributing to EHA’s annual congress…

hematology 8.1 featured image

Coagulopathy and Hyperinflammation in COVID-19

Clinical complications of COVID-19 include myocarditis, acute myocardial infarction, heart failure, venous thromboembolism, and cerebrovascular events…

EHA 2020 Interview: Prof Margarita Guevova

Prof Margarita Guevova | EHA Chair of European Board for Accreditation in HematologyNational Specialised Hospital for Active Treatment…

EHA 2020 Interview: Prof Antonio Almeida

Prof Antonio Almeida | European Hematology Association (EHA) Chair of the Curriculum CommitteeHead of Haematology, Hospital da Luz Lisboa…

EHA 2020 Interview: Dr Noémi Roy

Dr Noémi Roy | European Hematology Association (EHA) Guidelines Committee ChairConsultant Haematologist at Department of Haematology…

EHA 2020 Interview: Roundtable Interview with Dr Alba Maiques-Diaz and Dr Anna Kabanova

Roundtable interview with Dr Alba Maiques-Diaz and Dr Anna Kabanova

hematology 8.1 featured image

Paused Transcription: A Novel MIR139-Silencing Mechanism Downstream of MLL-AF9 in Acute Myeloid Leukaemia

The expression and tight regulation of microRNA is essential for haematopoiesis and the prevention of leukaemia…

Loading posts...

« Previous 1 … 67 68 69 70 71 … 100 Next »